HF
KURA icon

HRT Financial’s Kura Oncology KURA Stock Holding History

HRT Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Sell
214,747
-234,277
-52% -$2.21M ﹤0.01% 1643
2026
Q1 		$3.65M Buy
449,024
+350,995
+358% +$3.02M 0.01% 1188
2025
Q4 		$1.02M Sell
98,029
-270,528
-73% -$2.84M ﹤0.01% 1707
2025
Q3 		$3.26M Buy
368,557
+158,579
+76% +$1.13M 0.01% 885
2025
Q2 		$1.21M Buy
209,978
+49,661
+31% +$304K 0.01% 1171
2025
Q1 		$1.06M Buy
+160,317
New +$1.25M 0.01% 1093
2024
Q4 		– Sell
-44,007
Closed -$859K – 2861
2024
Q3 		$859K Buy
44,007
+305
+0.7% +$6.18K ﹤0.01% 1319
2024
Q2 		$899K Buy
+43,702
New +$898K 0.01% 1061
2024
Q1 		– Sell
-94,279
Closed -$1.35M – 2722
2023
Q4 		$1.35M Buy
+94,279
New +$927K 0.01% 841
2022
Q2 		– Sell
-32,072
Closed -$515K – 3340
2022
Q1 		$515K Buy
32,072
+16,026
+100% +$231K ﹤0.01% 1615
2021
Q4 		$224K Sell
16,046
-26,421
-62% -$428K ﹤0.01% 2465
2021
Q3 		$795K Buy
+42,467
New +$800K ﹤0.01% 1508
2020
Q1 		– Sell
-22,436
Closed -$308K – 1084
2019
Q4 		$308K Buy
+22,436
New +$332K 0.01% 730

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

HRT Financial's KURA Position: Q2 2026 in Review

HRT Financial reduced its Kura Oncology (KURA) stake by 52% in Q2 2026, selling an estimated $2.21M and leaving 214,747 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1643.

HRT Financial first reported a position in KURA in Q4 2019 and has held it in 13 quarters since. The position peaked at $3.65M in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • HRT Financial held 214,747 shares of Kura Oncology worth $2.35M as of Q2 2026.
  • HRT Financial sold 234,277 Kura Oncology shares in Q2 2026, an estimated $2.21M.
  • Kura Oncology made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1643 holding.
  • HRT Financial first reported a position in Kura Oncology in Q4 2019 and has held it in 13 quarters since.
  • HRT Financial's Kura Oncology position peaked at $3.65M in Q1 2026.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.